Cargando…
Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer’s Disease Associated with Down Syndrome
Limited comparative data exist on the molecular spectrum of amyloid-beta (Aβ) and tau deposition in individuals with Down syndrome (DS) and sporadic Alzheimer’s disease (sAD). We assessed Aβ and tau deposition severity in the temporal lobe and cerebellum of ten DS and ten sAD cases. Immunohistochemi...
Autores principales: | Ichimata, Shojiro, Martinez-Valbuena, Ivan, Lee, Seojin, Li, Jun, Karakani, Ali M., Kovacs, Gabor G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380583/ https://www.ncbi.nlm.nih.gov/pubmed/37511361 http://dx.doi.org/10.3390/ijms241411596 |
Ejemplares similares
-
Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer’s Disease
por: Lee, Ni-Chung, et al.
Publicado: (2017) -
JNK Activation
in Alzheimer’s Disease Is Driven
by Amyloid β and Is Associated with Tau Pathology
por: Solas, Maite, et al.
Publicado: (2023) -
Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer’s disease pathology in Down syndrome
por: Maxwell, Alison M., et al.
Publicado: (2021) -
The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
por: Yin, Xiaomin, et al.
Publicado: (2021) -
Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
por: Roda, Alejandro R., et al.
Publicado: (2022)